27 research outputs found
Performance characteristics of the serological tests used in this study, as reported by the manufacturer. Sen = Sensitivity, Spec = Specificity, n.p. = not provided.
<p>Performance characteristics of the serological tests used in this study, as reported by the manufacturer. Sen = Sensitivity, Spec = Specificity, n.p. = not provided.</p
Definitions used to determine the infectious stage of baboons.
<p>Definitions used to determine the infectious stage of baboons.</p
Comparison of the serological tests with the consensus of infection status (Table 2).
<p>Comparison of the serological tests with the consensus of infection status (<a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0003637#pntd.0003637.t002" target="_blank">Table 2</a>).</p
Multiple comparisons of log anti-<i>T</i>. <i>pallidum</i> titers in 4 groups with a different stage of genital ulceration in baboons
<p>([CNA] = clinically non-affected (n = 20), [INI] = initial (n = 14), [MOD] = moderate (n = 7), and [SEV] = severe genital ulceration (n = 16); for stage definition see [<a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0003637#pntd.0003637.ref018" target="_blank">18</a>]), GU = genital ulceration. Anti-<i>T</i>. <i>pallidum</i> antibody quantification was investigated using the Serodia TP-PA. Kruskal-Wallis test using Dunn’s correction for multiple comparison: CNA vs. SEV mean rank diff. = -30.04, p ≤ 0.0001; CNA vs. MOD mean rank diff. = -19.95, p ≤ 0.05; INI vs. SEV mean rank diff. = -17.56, p ≤ 0.05. (mean ± SEM).</p
<i>T</i>. <i>pallidum</i> test algorithm for the screening of wild non-treated baboons.
<p>Based on the test performances Espline TP is recommended as the initial screening test followed by a confirmatory test e.g. Mastablot TP IgG that has been identified as most reliable standard. Dashed lines indicate reported results, while continuous lines represent the workflow.</p
Comparison of treponemal serological tests with the results of the Serodia TP-PA.
<p>Comparison of treponemal serological tests with the results of the Serodia TP-PA.</p
Detection limits of LAMP assays.
<p>(A-C) <i>TP</i> LAMP assay involving (A) <i>TPA</i> strain Nichols with copy numbers 10E+5 to 10E+0, (B) <i>TPE</i> strain Gauthier tested in a range of 10E+6 to 10E+0 copies, and (C) <i>TEN</i> strain Bosnia A in 10E+6 to 10E+0 copy numbers. (D-E) <i>TPA</i> LAMP assay run with <i>TPA</i> strain Nichols from 10E+5 to 10E+0 copy numbers, and the same LAMP assay run with (E) <i>TEN</i> strain Bosnia A in copy numbers ranging from 10E+6 to 10E+0. (F-G) <i>TPE</i>/<i>TEN</i> LAMP assay involving (E) <i>TPE</i> strain Gauthier tested in 10E+6 to 10E+0 copy numbers, and (F) <i>TEN</i> strain Bosnia A tested in 10E+6 to 10E+0 copies. Red cross = Negative control, <i>TPA</i> strain Nichols (blue), <i>TPE</i> strain Gauthier (green), <i>TEN</i> strain Bosnia A (black); symbols represent copy numbers: circle with cross = 10E+6, hexagon = 10E+5, square turned = 10E+4, square = 10E+3, circle = 10E+2, down-pointing triangle = 10E+1, up-pointing triangle = 10E+0.</p
Gene target selection for loop-mediated isothermal amplification for rapid discrimination of <i>Treponema pallidum</i> subspecies
<div><p>We show proof of concept for gene targets (<i>polA</i>, <i>tprL</i>, and TP_0619) that can be used in loop-mediated isothermal amplification (LAMP) assays to rapidly differentiate infection with any of the three <i>Treponema pallidum</i> subspecies (<i>pallidum</i> (<i>TPA</i>), <i>pertenue</i> (<i>TPE</i>), and <i>endemicum</i> (<i>TEN</i>)) and which are known to infect humans and nonhuman primates (NHPs). Four <i>TPA</i>, six human, and two NHP <i>TPE</i> strains, as well as two human <i>TEN</i> strains were used to establish and validate the LAMP assays. All three LAMP assays were highly specific for the target DNA. Amplification was rapid (5–15 min) and within a range of 10E+6 to 10E+2 of target DNA molecules. Performance in NHP clinical samples was similar to the one seen in human <i>TPE</i> strains. The newly designed LAMP assays provide proof of concept for a diagnostic tool that enhances yaws clinical diagnosis. It is highly specific for the target DNA and does not require expensive laboratory equipment. Test results can potentially be interpreted with the naked eye, which makes it suitable for the use in remote clinical settings.</p></div
Simplified Real-Time Multiplex Detection of Loop-Mediated Isothermal Amplification Using Novel Mediator Displacement Probes with Universal Reporters
A variety
of real-time detection techniques for loop-mediated isothermal
amplification (LAMP) based on the change in fluorescence intensity
during DNA amplification enable simultaneous detection of multiple
targets. However, these techniques depend on fluorogenic probes containing
target-specific sequences. That complicates the adaption to different
targets leading to time-consuming assay optimization. Here, we present
the first universal real-time detection technique for multiplex LAMP.
The novel approach allows simple assay design and is easy to implement
for various targets. The innovation features a mediator displacement
probe and a universal reporter. During amplification of target DNA
the mediator is displaced from the mediator displacement probe. Then
it hybridizes to the reporter generating a fluorescence signal. The
novel mediator displacement (MD) detection was validated against state-of-the-art
molecular beacon (MB) detection by means of a HIV-1 RT-LAMP: MD surpassed
MB detection by accelerated probe design (MD: 10 min, MB: 3–4
h), shorter times to positive (MD 4.1 ± 0.1 min shorter than
MB, <i>n</i> = 36), improved signal-to-noise fluorescence
ratio (MD: 5.9 ± 0.4, MB: 2.7 ± 0.4; <i>n</i> =
15), and showed equally good or better analytical performance parameters.
The usability of one universal mediator-reporter set in different
multiplex assays was successfully demonstrated for a biplex RT-LAMP
of HIV-1 and HTLV-1 and a biplex LAMP of Haemophilus
ducreyi and Treponema pallidum, both showing good correlation between target concentration and
time to positive. Due to its simple implementation it is suggested
to extend the use of the universal mediator-reporter sets to the detection
of various other diagnostic panels
Detection limits for the three LAMP assays.
<p>Corresponding graphs can be found in <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0006396#pntd.0006396.g002" target="_blank">Fig 2</a>. + = exponential amplification, (+) = no exponential amplification,— = no amplification.</p